Withdrawal of Tiratricol Treatment in Males With Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency)

Clinical trial NCT05579327 · COMPLETED

Trial details

NCT number: NCT05579327
Sponsor: Rare Thyroid Therapeutics International AB
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Monocarboxylate Transporter 8 Deficiency Allan-Herndon-Dudley Syndrome

Start date: 2023-07-21
Primary completion: 2025-07-22
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.